Marked reduction in haemoglobin levels secondary to ceftizoxime‐induced immune haemolytic anaemia in diabetic patients
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.13135
Abstract: Drug‐induced immune haemolytic anaemia (DIIHA) is rare and difficult to diagnose. In diabetic patients, the diagnosis of DIIHA is even harder. In the current study, we report on two cases of ceftizoxime‐induced immune haemolytic anaemia… read more here.
Keywords: ceftizoxime induced; diabetic patients; induced immune; haemolytic anaemia ... See more keywords
Acute hepatitis B virus infection and severe non-immune haemolytic anaemia: a rare relationship
Sign Up to like & getrecommendations! Published in 2017 at "BMJ Case Reports"
DOI: 10.1136/bcr-2017-221763
Abstract: The clinical presentation of acute hepatitis B virus (HBV) infection is usually related to the onset of liver failure and damage. Anaemia may occur, but it is only rarely attributed to haemolysis. The authors report… read more here.
Keywords: acute; haemolytic anaemia; infection; non immune ... See more keywords
Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2021.697192
Abstract: There has previously been a report of a patient developing haemolytic anaemia following exposure to cefoperazone. Another case has been reported involving the detection of cefoperazone-dependent antibodies in the absence of immune haemolytic anaemia. To… read more here.
Keywords: cefoperazone; tazobactam sulbactam; report; haemolytic anaemia ... See more keywords